There is no interest UNTIL there is interest. Then its too late to get in. Just the way its played in small cap biotech land. The reason to get out is if the science is not successful. In CTIX's case they have all been successful. Hillary has killed interest in biotech in general, but this will pass valuations are getting crazy compelling.
If they can get it for $147 it would be a long term steal. Certainly would be transformative.
Wrong , I do this for a living. Go ahead and continue to believe that, meanwhile I made a boat load on CELG, AMGN, BMRN.all still going much higher,CELG. will be $120 before you can scratch your head looking puzzled at the IBB.
CELG AMGN, BIIB have broken their down trend. You are focused on the wrong thing. It's the leaders in biotech that will tell you if biotechs are going up, the IBB follows. The IBB is a trailing indicator for biotechs not a leading indicator.
I thought it was ridiculously cheap 2009 Recession pricing. Now the ethanol plants are on fire, Which will boost forward earnings. MPC should be interesting.
Exactly, I think that is the plan; otherwise he would have taken one of them all the way. They have a lot in the pipeline they haven't done anything with, so with the income stream they will keep developing more adding to the income stream. Getting harder and harder to bring up the message board. Yahoo trying to kill it. I am moving on to ihub and stocktwits once total access is removed.
Didn't say they were selling today. I think they are building up the value of the pipeline horizontally without going through PHIII trIals. To sell the current three candidates, partner the three with one or more companr most likely one, sell the Co outright, or keep one. That won't happen until some of these PICs or PII trials end.
to be bought out. They may already have interest for the pipeline by a suitor that is asking for more data on the breath of some of the drugs. To get the minimum ask. IMHO. Shorts on RYLP are in disbelief, shocked, acting disoriented. Same behavior I've observed on other Biotech's I've owned that have been BO like TRIUS, DRTX., etc.
Nothing. Buyout still in play. Biotechs selling in am. Look to reverse. Folks want to sell go ahead. An announcement could be forthcoming anytime. Buy more if you can.
Making lots of $$$. CTIX is a spec play. I own a lot of shares but never gave too much importance on P. I'd be more concerned with the upcoming B-OM results. I may add more CTIX, maybe if BMRN gets bought out. I think the new hire will make it clearer on the path forward for CTIX's pipeinr. There are alot of self proclaimed experts on law, patent law, molecular chemistry, without giving any benefit of the doubt to Dr. Menon, Leo, USPTO, etc. Of course the board posters must be believed versus the Company experts. Just don't make any rash investing decisions based on the Prurisol ping pong match.
If CS makes a fair value assessment in the $130 -- $150 range, it shows you how inane the market has valued a lot of biotechs. Maybe the catalyst's needed to get the sector moving up again.
I think they want to move prior to any SNY offer. Source said they were about to move, but put on hold due to Brexit...now is ready to move forward somewhat prompted that BMRN is a backup plan for SNY. I can't say one way or another, do you have an authoritative source, given your strong opinion?